SVR From DAA, Interferon-based Treatments for HCV and HCC Risk SVR From DAA, Interferon-based Treatments for HCV and HCC Risk
How does sustained virologic response from direct-acting antiviral and interferon-based treatments impact the risk of developing hepatocellular carcinoma?Journal of Viral Hepatitis
Source: Medscape Hiv-Aids Headlines - Category: Infectious Diseases Tags: Gastroenterology Journal Article Source Type: news
More News: Cancer & Oncology | Carcinoma | Gastroenterology | Hepatitis | Hepatocellular Carcinoma | HIV AIDS | Infectious Diseases | Liver Cancer | Virology